Benzinga | Feb 25, 2021 04:43PM EST

Axonics Modulation Tech Q4 Net Loss $11.3M vs $22.8M In Same Qtr. Last Year, Sales $34.80M Miss $35.11M Estimate

Axonics Modulation Tech (NASDAQ:AXNX) reported quarterly sales of $34.80 million which missed the analyst consensus estimate of $35.11 million by 0.88 percent. This is a 249.89 percent increase over sales of $9.95 million the same period last year.